In the present study, results of clinically relevant study suggested that bladder cancer patients with higher IGF2BP3 levels were more prone to poor overall survival, and higher IGF2BP3 expression was correlated with a significantly increased risk of death in bladder cancer patients. Here, IGF2BP3 is linked to urinary bladder carcinoma.